Advertisement
UK markets closed
  • FTSE 100

    8,275.38
    +44.33 (+0.54%)
     
  • FTSE 250

    20,730.12
    +59.25 (+0.29%)
     
  • AIM

    805.79
    +3.10 (+0.39%)
     
  • GBP/EUR

    1.1742
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2738
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    53,083.08
    -583.12 (-1.09%)
     
  • CMC Crypto 200

    1,422.82
    -5.75 (-0.40%)
     
  • S&P 500

    5,277.51
    +42.03 (+0.80%)
     
  • DOW

    38,686.32
    +574.84 (+1.51%)
     
  • CRUDE OIL

    77.18
    -0.73 (-0.94%)
     
  • GOLD FUTURES

    2,347.70
    -18.80 (-0.79%)
     
  • NIKKEI 225

    38,487.90
    +433.77 (+1.14%)
     
  • HANG SENG

    18,079.61
    -150.58 (-0.83%)
     
  • DAX

    18,497.94
    +1.15 (+0.01%)
     
  • CAC 40

    7,992.87
    +14.36 (+0.18%)
     

Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock Market

Nasdaq, Inc.
Nasdaq, Inc.

NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.’s securities were suspended on March 18, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares and warrants of Tritium DCFC Limited. Tritium DCFC Limited’s securities were suspended on April 22, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Arcimoto, Inc. Arcimoto, Inc.’s securities were suspended on May 1, 2024, and have not traded on Nasdaq since that time.

ADVERTISEMENT

Nasdaq also announced today that it will delist the ordinary shares of Next.e.GO N.V.. Next.e.GO N.V.’s securities were suspended on May 1, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Acutus Medical, Inc. Acutus Medical, Inc.’s securities were suspended on May 9, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.’s securities were suspended on May 13, 2024, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.